A Study of LAM-002A for the Prevention of Progression of COVID-19

NCT04446377 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Disease

Interventions

DRUG: Apilimod Dimesylate Capsule
OTHER: Placebo

Sponsor

OrphAI Therapeutics

Collaborators

[object Object]